What contributes to quality of life in patients with Parkinson's disease?

By A. Schrag, M. Jahanshahi, N. Quinn. Journal of Neurology Neurosurgery & Psychiatry, 2000

1,310 citations recorded by the source corpus.

Subfields: Neurology, Physical Therapy, Sports Therapy and Rehabilitation

View Paper: https://www.semanticscholar.org/paper/620c214195ff7e6819bc1ec2158af3404cbeb8df

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Neurology

In Physical Therapy, Sports Therapy and Rehabilitation

Kallol Ray Chaudhuri

Citations in the corpus

Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 years (2005, background): “Total considered (N) 126 10 136 Lost to follow up 3 (2) 3 (30) 6 (4) Interviewed at 15 yr 51 (40) 1 (10) 52 (38) Death prior to yr 15 interview 72 (57) 5 (50) 77 (57) Accounted for at 15 yr 123 (98) 7 (70) 130 (96) Total known deaths 77 (61) 5 (50) 82 (60)”
Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. (2007, background): “Furthermore, dementia has a major impact on quality of life (Schrag et al., 2000) and prognosis (Nussbaum et al., 1998), as well as being an important risk factor for nursing home placement (Aarsland et al., 2000), with consequent major health economics implications (Findley et al., 2003).”
The metric properties of a novel non‐motor symptoms scale for Parkinson's disease: Results from an international pilot study (2007, background): “Maximum score (standardized to percentage on the maximum possible score) was recorded for six domains: sleep (3 patients); mood (2); perceptual disorders (1); attention/memory (4); urinary (4); and sexual function (5).”
Metabolic brain networks associated with cognitive function in Parkinson's disease (2007, background): “Such subtle behavioral/cognitive deficits may have a major impact on the quality of life of PD patients (Schrag et al., 2000).”
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. (2009, background): “, 2003) and have a major impact on quality of life (Schrag et al., 2000), survival (Buter et al.”
A systematic review of prevalence studies of depression in Parkinson's disease (2008, background): “Another 7 studies used patients from a combination of different settings: population and outpatient samples (4), outpatient and inpatient samples (2), and outpatient and nursing home samples (1).”